NewAmsterdam Pharma (NAMS) Earnings Date & Reports

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NAMS is expected to report earnings to rise 40.34% to -49 cents per share on August 12

NewAmsterdam Pharma NAMS Stock Earnings Reports

Q2'25

Est.

$-0.49

Q1'25

Beat

by $0.15

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.32

Q2'24

Beat

by $0.17

The last earnings report on May 08 showed earnings per share of -34 cents, beating the estimate of -49 cents. With 466.89K shares outstanding, the current market capitalization sits at 2.11B.

View a ticker or compare two or three

Compare

NAMS